Animal Galectins and Plant Lectins as Tools for Studies in Neurosciences
Tóm tắt
Từ khóa
Tài liệu tham khảo
Sharon N.; Lis H.; History of lectins: from hemagglutinins to biological recognition molecules. Glycobiology 2004,14(11),53R-62R
Van Dammes E.J.; Fouquaert E.; Lannoo N.; Vandenborre G.; Schouppe D.; Peumans W.J.; Novel concepts about the role of lectins in the plant cell. Adv Exp Med Biol 2011,705,271-294
Vijayan M.C.; Chandra N.; Lectins current opinion. J Struct Biol 1999,9,707-714
Harrison F.L.; Soluble vertebrate lectins: ubiquitous but inscrutable proteins. J Cell Sci 1991,100(Pt 1),9-14
Barondes S.H.; Cooper D.N.W.; Gitt M.A.; Leffler H.; Galectins. Structure and function of a large family of animal lectins. J Biol Chem 1994,269(33),20807-20810
Loh S.H.; Park J.Y.; Cho E.H.; Nah S.Y.; Kang Y.S.; Animal lectins: potential receptors for ginseng polysaccharides. J Ginseng Res 2017,41(1),1-9
Peumans W.J.; Van Damme J.M.; Barre A.; Rougé P.; Classification of Plant Lectins in Families Of Structurally and Evolutionary Related Proteins. Molecular Immunol Complex Carbohydrates —2 2001,491,27-54
Peumans W.J.; Van Damme E.J.M.; Lectins as plant defense proteins. Plant Physiol 1995,109(2),347-352
Trindade M.B.; Lopes J.L.S.; Soares-Costa A.; Monteiro-Moreira A.C.O.; Moreira R.A.; Oliva M.L.V.; Beltramini L.M.; Structural characterization of novel chitin-binding lectins from the genus Artocarpus and their antifungal activity. Biochim Biophys Acta 2006,1764(1),146-152
Keyaerts E.; Vijgen L.; Pannecouque C.; Van Damme E.; Peumans W.; Egberink H.; Balzarini J.; Van Ranst M.; Plant lectins are potent inhibitors of coronaviruses by interfering with two targets in the viral replication cycle. Antiviral Res 2007,75(3),179-187
Carvalho Ade.S.; da Silva, M.V.; Gomes, F.S.; Paiva, P.M.G.; Malafaia, C.B.; da Silva, T.D.; Vaz, A.F.M.; da Silva, A.G.; Arruda, I.R.S.; Napoleão, T.H.; Carneiro-da-Cunha, Md.; Correia, M.T.S. Purification, characterization and antibacterial potential of a lectin isolated from Apuleia leiocarpa seeds. Int J Biol Macromol 2015,75,402-408
Silva H.C.; Bari A.U.; Rocha B.A.M.; Nascimento K.S.; Ponte E.L.; Pires A.F.; Delatorre P.; Teixeira E.H.; Debray H.; Assreuy A.M.S.; Nagano C.S.; Cavada B.S.; Purification and primary structure of a mannose/glucose-binding lectin from Parkia biglobosa Jacq. seeds with antinociceptive and anti-inflammatory properties. J Mol Recognit 2013,26(10),470-478
Campos J.K.L.; Araújo C.S.F.; Araújo T.F.S.; Santos A.F.S.; Teixeira J.A.; Lima V.L.M.; Coelho L.C.B.B.; Anti-inflammatory and antinociceptive activities of Bauhinia monandra leaf lectin. Biochim Open 2016,2,62-68
Fontenelle T.P.C.; Lima G.C.; Mesquita J.X.; Lopes J.L.S.; de Brito T.V.; Vieira Júnior F.D.C.; Sales A.B.; Aragão K.S.; Souza M.H.L.P.; Barbosa A.L.D.R.; Freitas A.L.P.; Lectin obtained from the red seaweed Bryothamnion triquetrum: Secondary structure and anti-inflammatory activity in mice. Int J Biol Macromol 2018,112,1122-1130
Kabir S.R.L.; Reza M.A.; Antibacterial activity of Kaempferia rotunda rhizome lectin and its induction of apoptosis in Ehrlich ascites carcinoma cells. Appl Biochem Biotechnol 2014,172(6),2866-2876
Ahmed F.R.S.; Amin R.; Hasan I.; Asaduzzaman A.K.M.; Kabir S.R.; Antitumor properties of a methyl-β-d-galactopyranoside specific lectin from Kaempferia rotunda against Ehrlich ascites carcinoma cells. Int J Biol Macromol 2017,102,952-959
Pathan J.; Mondal S.; Sarkar A.; Chakrabarty D.; Daboialectin, a C-type lectin from Russell’s viper venom induces cytoskeletal damage and apoptosis in human lung cancer cells in vitro. Toxicon 2017,127,11-21
Vanderlei E.S.O.; Patoilo K.K.N.R.; Lima N.A.; Lima A.P.S.; Rodrigues J.A.G.; Silva L.M.C.M.; Lima M.E.P.; Lima V.; Benevides N.M.B.; Antinociceptive and anti-inflammatory activities of lectin from the marine green alga Caulerpa cupressoides. Int Immunopharmacol 2010,10(9),1113-1118
Silva L.M.C.M.; Lima V.; Holanda M.L.; Pinheiro P.G.; Rodrigues J.A.G.; Lima M.E.P.; Benevides N.M.B.; Antinociceptive and anti-inflammatory activities of lectin from marine red alga Pterocladiella capillacea. Biol Pharm Bull 2010,33(5),830-835
Damasceno M.B.M.V.; de Melo Júnior, Jde.M.; Santos, S.A.A.R.; Melo, L.T.M.; Leite, L.H.I.; Vieira-Neto, A.E.; Moreira, Rde.A.; Monteiro-Moreira, A.C.O.; Campos, A.R. Frutalin reduces acute and neuropathic nociceptive behaviours in rodent models of orofacial pain. Chem Biol Interact 2016,256,9-15
Panjwani N.; Role of galectins in re-epithelialization of wounds. Ann Transl Med 2014,2(9),89
Cao Z.; Saravanan C.; Chen W.S.; Panjwani N.; Examination of the role of galectins in cell migration and re-epithelialization of wounds. 2015
de Sousa F.D.; Vasconselos P.D.; da Silva A.F.B.; Mota E.F.; da Rocha Tomé A.; Mendes F.R.D.S.; Gomes A.M.M.; Abraham D.J.; Shiwen X.; Owen J.S.; Lourenzoni M.R.; Campos A.R.; Moreira R.A.; Monteiro-Moreira A.C.O.; Hydrogel and membrane scaffold formulations of Frutalin (breadfruit lectin) within a polysaccharide galactomannan matrix have potential for wound healing. Int J Biol Macromol 2019,121,429-442
Yang R.Y.; Rabinovich G.A.; Liu F.T.; Galectins: structure, function and therapeutic potential. Expert Rev Mol Med 2008,10
Russi M.A.; Vandresen-Filho S.; Rieger D.K.; Costa A.P.; Lopes M.W.; Cunha R.M.; Teixeira E.H.; Nascimento K.S.; Cavada B.S.; Tasca C.I.; Leal R.B.; ConBr, a lectin from Canavalia brasiliensis seeds, protects against quinolinic acid-induced seizures in mice. Neurochem Res 2012,37(2),288-297
Cavada B.S.; Barbosa T.; Arruda S.; Grangeiro T.B.; Barral-Netto M.; Revisiting proteus: do minor changes in lectin structure matter in biological activity? Lessons from and potential biotechnological uses of the Diocleinae subtribe lectins. Curr Protein Pept Sci 2001,2(2),123-135
Yagi H.; Kato K.; Functional roles of glycoconjugates in the maintenance of stemness and differentiation process of neural stem cells. Glycoconj J 2017,34(6),757-763
Le Mercier M.; Fortin S.; Mathieu V.; Kiss R.; Lefranc F.; Galectins and gliomas. Brain Pathol 2010,20(1),17-27
Starossom S.C.; Mascanfroni I.D.; Imitola J.; Cao L.; Raddassi K.; Hernandez S.F.; Bassil R.; Croci D.O.; Cerliani J.P.; Delacour D.; Wang Y.; Elyaman W.; Khoury S.J.; Rabinovich G.A.; Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration. Immunity 2012,37(2),249-263
Abreu T.M.; Monteiro V.S.; Martins A.B.S.; Teles F.B.; da Conceição Rivanor R.L.; Mota É.F.; Macedo D.S.; de Vasconcelos S.M.M.; Júnior J.E.R.H.; Benevides N.M.B.; Involvement of the dopaminergic system in the antidepressant-like effect of the lectin isolated from the red marine alga Solieria filiformis in mice. Int J Biol Macromol 2018,111,534-541
Stillmark H.; Über Ricin ein giftiges Ferment aus den Samen von Ricinus communis L und einige anderen Euphorbiaceen Inaugural Dissertation,University of Tartu: Dorpat.1888
Boyd W.C.; Shapleigh E.; Specific precipitating activity of plant agglutinins (lectins). Science 1954,119(3091),419
Bies C.; Lehr C.M.; Woodley J.F.; Lectin-mediated drug targeting: history and applications. Adv Drug Deliv Rev 2004,56(4),425-435
Van Damme E.J.M.; Peumans W.J.; Barre A.; Rouge P.; Plant lectins: A composite of several distinct families of structurally and evolutionary related proteins with diverse biological roles. Crit Rev Plant Sci 1998,17,575-692
Moreira Rde.A.; Ainouz I.L.; De Oliveira J.T.; Cavada B.S.; Plant lectins, chemical and biological aspects. Mem Inst Oswaldo Cruz 1991,86(Suppl. 2),211-218
Spilatro S.R.; Cochran G.R.; Walker R.E.; Cablish K.L.; Bittner C.C.; Characterization of a new lectin of soybean vegetative tissues. Plant Physiol 1996,110(3),825-834
Jesberger J.A.; Richardson J.S.; Neurochemical aspects of depression: the past and the future? Int J Neurosci 1985,27(1-2),19-47
Sapolsky R.M.; Why Zebras Don’t Get Ulcers 2004
Fenoglio C.; Genetics and epigenetics in the neurodegenerative disorders of the central nervous system. Neurodegeneriative Diseases 2018,1-20
Braga J.E.F.; Pordeus L.C.; Silva A.T.M.C.; Pimenta F.C.F.; Diniz M.F.F.M.; Almeida R.N.; Ansiedade Patológica: Bases Neurais e Avanços na Abordagem Psicofarmacológica. Rev. Bras. Ciên. Saúde 2010,14,93-100
Papakostas G.I.; The efficacy, tolerability, and safety of contemporary antidepressants 2010,71(Suppl E1)
Tohyama K.; The localization of lectin-binding sites on Schwann cell basal lamina. J Neurocytol 1985,14(1),49-61
Lin S.S.; Levitan I.B.; Concanavalin A: a tool to investigate neuronal plasticity. Trends Neurosci 1991,14(7),273-277
Scherer W.J.; Udin S.B.; Concanavalin A reduces habituation in the tectum of the frog. Brain Res 1994,667(2),209-215
Boehm S.; Huck S.; Presynaptic inhibition by concanavalin A: are alpha-latrotoxin receptors involved in action potential-dependent transmitter release? J Neurochem 1998,71(6),2421-2430
Thalhammer A.; Everts I.; Hollmann M.; Inhibition by lectins of glutamate receptor desensitization is determined by the lectin’s sugar specificity at kainate but not AMPA receptors. Mol Cell Neurosci 2002,21(4),521-533
Fay A.M.; Bowie D.; Concanavalin-A reports agonist-induced conformational changes in the intact GluR6 kainate receptor. J Physiol 2006,572(Pt 1),201-213
Moreira R.A.; Cavada B.S.; Lectin from Canavalia brasiliensis Mart. Isolation, characterization and behavior during germination. Biol Plant 1984,26,113-120
Sanz-Aparicio J.; Hermoso J.; Grangeiro T.B.; Calvete J.J.; Cavada B.S.; The crystal structure of Canavalia brasiliensis lectin suggests a correlation between its quaternary conformation and its distinct biological properties from Concanavalin A. FEBS Lett 1997,405(1),114-118
Rieger D.K.; Navarro E.; Buendia I.; Parada E.; González-Lafuente L.; Leon R.; Costa A.P.; Heinrich I.A.; Nascimento K.S.; Cavada B.S.; Lopez M.G.; Egea J.; Leal R.B.; ConBr, A Lectin Purified from the Seeds of Canavalia brasiliensis, Protects Against Ischemia in Organotypic Culture of Rat Hippocampus: Potential Implication of Voltage-Gated Calcium Channels. Neurochem Res 2017,42(2),347-359
Jacques A.V.; Avaliação do Efeito Neuroprotetor de Lectinas Frente à Neurotoxicidade Glutamatérgica PhD Thesis, Universidade Federal de Santa Catarina: Florianópolis2012
Jacques A.V.; Rieger D.K.; Maestri M.; Lopes M.W.; Peres T.V.; Gonçalves F.M.; Pedro D.Z.; Tasca C.I.; López M.G.; Egea J.; Nascimento K.S.; Cavada B.S.; Leal R.B.; Leal R.B.; Lectin from Canavalia brasiliensis (ConBr) protects hippocampal slices against glutamate neurotoxicity in a manner dependent of PI3K/Akt pathway. Neurochem Int 2013,62(6),836-842
Barauna S.C.; Kaster M.P.; Heckert B.T.; do Nascimento K.S.; Rossi F.M.; Teixeira E.H.; Cavada B.S.; Rodrigues A.L.; Leal R.B.; Antidepressant-like effect of lectin from Canavalia brasiliensis (ConBr) administered centrally in mice. Pharmacol Biochem Behav 2006,85(1),160-169
Rieger D.K.; Costa A.P.; Budni J.; Moretti M.; Barbosa S.G.R.; Nascimento K.S.; Teixeira E.H.; Cavada B.S.; Rodrigues A.L.; Leal R.B.; Leal R.B.; Antidepressant-like effect of Canavalia brasiliensis (ConBr) lectin in mice: evidence for the involvement of the glutamatergic system. Pharmacol Biochem Behav 2014,122,53-60
Araújo J.R.C.; Júnior J.M.A.M.; Damasceno M.B.M.V.; Santos S.A.A.R.; Vieira-Neto A.E.; Lobo M.D.P.; Campos A.R.; Moreira R.A.; Monteiro-Moreira A.C.O.; Neuropharmacological characterization of frutalin in mice: Evidence of an antidepressant-like effect mediated by the NMDA receptor/NO/cGMP pathway. Int J Biol Macromol 2018,112,548-554
Gonçalves F.M.; Freitas A.E.; Peres T.V.; Rieger D.K.; Ben J.; Maestri M.; Costa A.P.; Tramontina A.C.; Gonçalves C.A.; Rodrigues A.L.; Nagano C.S.; Teixeira E.H.; Nascimento K.S.; Cavada B.S.; Leal R.B.; Vatairea macrocarpa lectin (VML) induces depressive-like behavior and expression of neuroinflammatory markers in mice. Neurochem Res 2013,38(11),2375-2384
Leal R.B.; Pinto-Junior V.R.; Osterne V.J.S.; Wolin I.A.V.; Nascimento A.P.M.; Neco A.H.B.; Araripe D.A.; Welter P.G.; Neto C.C.; Correia J.L.A.; Rocha C.R.C.; Nascimento K.S.; Cavada B.S.; Crystal structure of DlyL, a mannose-specific lectin from Dioclea lasiophylla Mart. Ex Benth seeds that display cytotoxic effects against C6 glioma cells. Int J Biol Macromol 2018,114,64-76
Nascimento A.P.M.; Knaut J.L.; Rieger D.K.; Wolin I.A.V.; Heinrich I.A.; Mann J.; Juarez A.V.; Sosa L.D.V.; De Paul A.L.; Moreira C.G.; Silva I.B.; Nobre C.S.; Osterne V.J.S.; Nascimento K.S.; Cavada B.S.; Leal R.B.; Anti-glioma properties ofDVL, a lectin purified from Dioclea violacea. Int J Biol Macromol 2018,120(Pt A),566-577
Pratt J.; Roy R.; Annabi B.; Concanavalin-A-induced autophagy biomarkers requires membrane type-1 matrix metalloproteinase intracellular signaling in glioblastoma cells. Glycobiology 2012,22(9),1245-1255
Pratt J.; Annabi B.; Induction of autophagy biomarker BNIP3 requires a JAK2/STAT3 and MT1-MMP signaling interplay in Concanavalin-A-activated U87 glioblastoma cells. Cell Signal 2014,26(5),917-924
Beltrão E.I.; Medeiros P.L.; Rodrigues O.G.; Figueredo-Silva J.; Valença M.M.; Coelho L.C.B.B.; Carvalho L.B.; Parkia pendula lectin as histochemistry marker for meningothelial tumour. Eur J Histochem 2003,47(2),139-142
Bordet J.; Gay F.P.; ‘Sur les Relations des Sensibilactrices avec l’Aléxine’. Ann Inst Pasteur (Paris) 1906,20,467-498
Brinda K.V.; Surolia A.; Vishveshwara S.; Insights into the quaternary association of proteins through structure graphs: a case study of lectins. Biochem J 2005,391(Pt 1),1-15
Gabius H.J.; Wu A.M.; The emerging functionality of endogenous lectins: A primer to the concept and a case study on galectins including medical implications. Chang Gung Med J 2006,29(1),37-62
Kilpatrick D.C.; Animal lectins: a historical introduction and overview. Biochim Biophys Acta 2002,1572(2-3),187-197
Anderson K.E.D.; Rice K.G.; Structure and function of mammalian carbohydrate-lectin interactions 2008,2445-2482
Stillman B.N.; Mischel P.S.; Baum L.G.; New roles for galectins in brain tumors--from prognostic markers to therapeutic targets. Brain Pathol 2005,15(2),124-132
Endo T.; Glycans and glycan-binding proteins in brain: galectin-1-induced expression of neurotrophic factors in astrocytes. Curr Drug Targets 2005,6(4),427-436
Sakaguchi M.; Imaizumi Y.; Okano H.; Expression and function of galectin-1 in adult neural stem cells. Cell Mol Life Sci 2007,64(10),1254-1258
Motohashi T.; Nishioka M.; Kitagawa D.; Kawamura N.; Watanabe N.; Wakaoka T.; Kadoya T.; Kunisada T.; Galectin-1 enhances the generation of neural crest cells. Int J Dev Biol 2017,61(6-7),407-413
Morris S.; Ahmad N.; André S.; Kaltner H.; Gabius H.J.; Brenowitz M.; Brewer F.; Quaternary solution structures of galectins-1, -3, and -7. Glycobiology 2004,14(3),293-300
Suzuki Y.; Inoue T.; Yoshimaru T.; Ra C.; Galectin-3 but not galectin-1 induces mast cell death by oxidative stress and mitochondrial permeability transition. Biochim Biophys Acta 2008,1783(5),924-934
Liu F.T.; Patterson R.J.; Wang J.L.; Intracellular functions of galectins. Biochim Biophys Acta 2002,1572(2-3),263-273
Yang R.Y.; Rabinovich G.A.; Liu F.T.; Galectins: structure, function and therapeutic potential. Expert Rev Mol Med 2008,10
Larsen L.; Chen H-Y.; Saegusa J.; Liu F-T.; Galectin-3 and the skin. J Dermatol Sci 2011,64(2),85-91
van der Hoeven N.W.; Hollander M.R.; Yıldırım C.; Jansen M.F.; Teunissen P.F.; Horrevoets A.J.; van der Pouw Kraan T.C.; van Royen N.; The emerging role of galectins in cardiovascular disease. Vascul Pharmacol 2016,81,31-41
Chen H.L.; Liao F.; Lin T.N.; Liu F.T.; Galectins and Neuroinflammation. Glycobiology Nervous System 2014,Vol. 9,517-542
Stancic M.; van Horssen J.; Thijssen V.L.; Gabius H-J.; van der Valk P.; Hoekstra D.; Baron W.; Increased expression of distinct galectins in multiple sclerosis lesions. Neuropathol Appl Neurobiol 2011,37(6),654-671
Heilmann S.; Hummel T.; Margolis F.L.; Kasper M.; Witt M.; Immunohistochemical distribution of galectin-1, galectin-3, and olfactory marker protein in human olfactory epithelium. Histochem Cell Biol 2000,113(3),241-245
Ishibashi S.; Kuroiwa T.; Sakaguchi M.; Sun L.; Kadoya T.; Okano H.; Mizusawa H.; Galectin-1 regulates neurogenesis in the subventricular zone and promotes functional recovery after stroke. Exp Neurol 2007,207(2),302-313
Yan Y-P.; Lang B.T.; Vemuganti R.; Dempsey R.J.; Galectin-3 mediates post-ischemic tissue remodeling. Brain Res 2009,1288,116-124
Lerman B.J.; Hoffman E.P.; Sutherland M.L.; Bouri K.; Hsu D.K.; Liu F-T.; Rothstein J.D.; Knoblach S.M.; Deletion of galectin-3 exacerbates microglial activation and accelerates disease progression and demise in a SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Brain Behav 2012,2(5),563-575
Stancic M.; Slijepcevic D.; Nomden A.; Vos M.J.; de Jonge J.C.; Sikkema A.H.; Gabius H-J.; Hoekstra D.; Baron W.; Galectin-4, a novel neuronal regulator of myelination. Glia 2012,60(6),919-935
Hadari Y.R.; Paz K.; Dekel R.; Mestrovic T.; Accili D.; Zick Y.; Galectin-8. A new rat lectin, related to galectin-4. J Biol Chem 1995,270(7),3447-3453
Yoshida H.; Imaizumi T.; Kumagai M.; Kimura K.; Satoh C.; Hanada N.; Fujimoto K.; Nishi N.; Tanji K.; Matsumiya T.; Mori F.; Cui X-F.; Tamo W.; Shibata T.; Takanashi S.; Okumura K.; Nakamura T.; Wakabayashi K.; Hirashima M.; Sato Y.; Satoh K.; Interleukin-1beta stimulates galectin-9 expression in human astrocytes. Neuroreport 2001,12(17),3755-3758
Liu F-T.; Rabinovich G.A.; Galectins as modulators of tumour progression. Nat Rev Cancer 2005,5(1),29-41
Varki A.; Cummings R.D.; ESKO J.D.; Stanley P.; Hart G.W.; Aebi M.; Darvill A.G.; Kinoshita T.; Packer N.H.; Prestegard J.H.; Schanaar R.L.; Seeberger P.H.; Essentials of Glycobiology 2009
Kuwabara I.; Kuwabara Y.; Yang R.Y.; Schuler M.; Green D.R.; Zuraw B.L.; Hsu D.K.; Liu F.T.; Galectin-7 (PIG1) exhibits pro-apoptotic function through JNK activation and mitochondrial cytochrome c release. J Biol Chem 2002,277(5),3487-3497
von Wolff M.; Wang X.; Gabius H.J.; Strowitzki T.; Galectin fingerprinting in human endometrium and decidua during the menstrual cycle and in early gestation. Mol Hum Reprod 2005,11(3),189-194
Rabinovich G.A.; Toscano M.A.; Turning ‘sweet’ on immunity: galectin-glycan interactions in immune tolerance and inflammation. Nat Rev Immunol 2009,9(5),338-352
Dani N.; Broadie K.; Glycosylated synaptomatrix regulation of trans-synaptic signaling. Dev Neurobiol 2012,72(1),2-21
Curciarello R.; Steele A.; Cooper D.; MacDonald T.T.; Kruidenier L.; Kudo T.; The role of Galectin-1 and Galectin-3 in the mucosal immune response to Citrobacter rodentium infection. PLoS One 2014,9(9)
Gendronneau G.; Sanii S.; Dang T.; Deshayes F.; Delacour D.; Pichard E.; Advedissian T.; Sidhu S.S.; Viguier M.; Magnaldo T.; Poirier F.; Overexpression of galectin-7 in mouse epidermis leads to loss of cell junctions and defective skin repair. PLoS One 2015,10(3)
Simpson D.L.; Thorne D.R.; Loh H.H.; Developmentally regulated lectin in neonatal rat brain. Nature 1977,266(5600),367-369
Bladier D.; Joubert R.; Avellana-Adalid V.; Kémény J.L.; Doinel C.; Amouroux J.; Caron M.; Purification and characterization of a galactoside-binding lectin from human brain. Arch Biochem Biophys 1989,269(2),433-439
Lutomski D.; Caron M.; Bourin P.; Lefebure C.; Bladier D.; Joubert-Caron R.; Purification and characterization of natural antibodies that recognize a human brain lectin. J Neuroimmunol 1995,57(1-2),9-15
Lee R.T.; Ichikawa Y.; Allen H.J.; Lee Y.C.; Binding characteristics of galactoside-binding lectin (galaptin) from human spleen. J Biol Chem 1990,265(14),7864-7871
Cho M.; Cummings R.D.; Galectin-1, a beta-galactoside-binding lectin in Chinese hamster ovary cells. I. Physical and chemical characterization. J Biol Chem 1995,270(10),5198-5206
McGraw J.; Gaudet A.D.; Oschipok L.W.; Kadoya T.; Horie H.; Steeves J.D.; Tetzlaff W.; Ramer M.S.; Regulation of neuronal and glial galectin-1 expression by peripheral and central axotomy of rat primary afferent neurons. Exp Neurol 2005,195(1),103-114
Vas V.; Fajka-Boja R.; Ion G.; Dudics V.; Monostori E.; Uher F.; Biphasic effect of recombinant galectin-1 on the growth and death of early hematopoietic cells. Stem Cells 2005,23(2),279-287
Puche A.C.; Poirier F.; Hair M.; Bartlett P.F.; Key B.; Role of galectin-1 in the developing mouse olfactory system. Dev Biol 1996,179(1),274-287
Camby I.; Le Mercier M.; Lefranc F.; Kiss R.; Galectin-1: a small protein with major functions. Glycobiology 2006,16(11),137R-157R
Akazawa C.; Nakamura Y.; Sango K.; Horie H.; Kohsaka S.; Distribution of the galectin-1 mRNA in the rat nervous system: its transient upregulation in rat facial motor neurons after facial nerve axotomy. Neuroscience 2004,125(1),171-178
Sango K.; Tokashiki A.; Ajiki K.; Horie M.; Kawano H.; Watabe K.; Horie H.; Kadoya T.; Synthesis, localization and externalization of galectin-1 in mature dorsal root ganglion neurons and Schwann cells. Eur J Neurosci 2004,19(1),55-64
Cortegano I.; del Pozo V.; Cárdaba B.; de Andrés B.; Gallardo S.; del Amo A.; Arrieta I.; Jurado A.; Palomino P.; Liu F-T.; Lahoz C.; Galectin-3 down-regulates IL-5 gene expression on different cell types. J Immunol 1998,161(1),385-389
Narciso M.S.; Mietto, Bde.S.; Marques, S.A.; Soares, C.P.; Mermelstein, Cdos.S.; El-Cheikh, M.C.; Martinez, A.M.B. Sciatic nerve regeneration is accelerated in galectin-3 knockout mice. Exp Neurol 2009,217(1),7-15
Mendonça H.R.; Carvalho J.N.A.; Abreu C.A.; Mariano de Souza Aguiar Dos Santos D.; Carvalho J.R.; Marques S.A.; da Costa Calaza K.; Martinez A.M.B.; Lack of Galectin-3 attenuates neuroinflammation and protects the retina and optic nerve of diabetic mice. Brain Res 2018,1700,126-137
Mostacada K.; Oliveira F.L.; Villa-Verde D.M.; Martinez A.M.B.; Lack of galectin-3 improves the functional outcome and tissue sparing by modulating inflammatory response after a compressive spinal cord injury. Exp Neurol 2015,271,390-400
Pesheva P.; Kuklinski S.; Schmitz B.; Probstmeier R.; Galectin-3 promotes neural cell adhesion and neurite growth. J Neurosci Res 1998,54(5),639-654
Pasquini L.A.; Millet V.; Hoyos H.C.; Giannoni J.P.; Croci D.O.; Marder M.; Liu F.T.; Rabinovich G.A.; Pasquini J.M.; Galectin-3 drives oligodendrocyte differentiation to control myelin integrity and function. Cell Death Differ 2011,18(11),1746-1756
Regan L.J.; Dodd J.; Barondes S.H.; Jessell T.M.; Selective expression of endogenous lactose-binding lectins and lactoseries glycoconjugates in subsets of rat sensory neurons. Proc Natl Acad Sci USA 1986,83(7),2248-2252
Hynes M.A.; Gitt M.; Barondes S.H.; Jessell T.M.; Buck L.B.; Selective expression of an endogenous lactose-binding lectin gene in subsets of central and peripheral neurons. J Neurosci 1990,10(3),1004-1013
Inagaki Y.; Sohma Y.; Horie H.; Nozawa R.; Kadoya T.; Oxidized galectin-1 promotes axonal regeneration in peripheral nerves but does not possess lectin properties. Eur J Biochem 2000,267(10),2955-2964
McGraw J.; McPhail L.T.; Oschipok L.W.; Horie H.; Poirier F.; Steeves J.D.; Ramer M.S.; Tetzlaff W.; Galectin-1 in regenerating motoneurons. Eur J Neurosci 2004,20(11),2872-2880
Miura T.; Takahashi M.; Horie H.; Kurushima H.; Tsuchimoto D.; Sakumi K.; Nakabeppu Y.; Galectin-1beta, a natural monomeric form of galectin-1 lacking its six amino-terminal residues promotes axonal regeneration but not cell death. Cell Death Differ 2004,11(10),1076-1083
Horie H.; Kadoya T.; Sango K.; Hasegawa M.; Oxidized galectin-1 is an essential factor for peripheral nerve regeneration. Curr Drug Targets 2005,6(4),385-394
Quintá H.R.; Pasquini J.M.; Rabinovich G.A.; Pasquini L.A.; Glycan-dependent binding of galectin-1 to neuropilin-1 promotes axonal regeneration after spinal cord injury. Cell Death Differ 2014,21(6),941-955
Takaku S.; Niimi N.; Kadoya T.; Yako H.; Tsukamoto M.; Sakumi K.; Nakabeppu Y.; Horie H.; Sango K.; Galectin-1 and galectin-3 as key molecules for peripheral nerve degeneration and regeneration. AIMS Mol Sci 2016,3,325-337
Wu G.; Lu Z.H.; André S.; Gabius H.J.; Ledeen R.W.; Functional interplay between ganglioside GM1 and cross-linking galectin-1 induces axon-like neuritogenesis via integrin-based signaling and TRPC5-dependent Ca influx. J Neurochem 2016,136(3),550-563
Horie H.; Kadoya T.; Hikawa N.; Sango K.; Inoue H.; Takeshita K.; Asawa R.; Hiroi T.; Sato M.; Yoshioka T.; Ishikawa Y.; Oxidized galectin-1 stimulates macrophages to promote axonal regeneration in peripheral nerves after axotomy. J Neurosci 2004,24(8),1873-1880
Gaudet A.D.; Sweet D.R.; Polinski N.K.; Guan Z.; Popovich P.G.; Galectin-1 in injured rat spinal cord: implications for macrophage phagocytosis and neural repair. Mol Cell Neurosci 2015,64,84-94
Velasco S.; Díez-Revuelta N.; Hernández-Iglesias T.; Kaltner H.; André S.; Gabius H-J.; Abad-Rodríguez J.; Neuronal Galectin-4 is required for axon growth and for the organization of axonal membrane L1 delivery and clustering. J Neurochem 2013,125(1),49-62
Wada M.; Ono S.; Kadoya T.; Kawanami T.; Kurita K.; Kato T.; Decreased galectin-1 immunoreactivity of the skin in amyotrophic lateral sclerosis. J Neurol Sci 2003,208(1-2),67-70
Rinaldi M.; Thomas L.; Mathieu P.; Carabias P.; Troncoso M.F.; Pasquini J.M.; Rabinovich G.A.; Pasquini L.A.; Galectin-1 circumvents lysolecithin-induced demyelination through the modulation of microglial polarization/phagocytosis and oligodendroglial differentiation. Neurobiol Dis 2016,96,127-143
Lutomski D.; Joubert-Caron R.; Lefebure C.; Salama J.; Belin C.; Bladier D.; Caron M.; Anti-galectin-1 autoantibodies in serum of patients with neurological diseases. Clin Chim Acta 1997,262(1-2),131-138
Kato T.; Kurita K.; Seino T.; Kadoya T.; Horie H.; Wada M.; Kawanami T.; Daimon M.; Hirano A.; Galectin-1 is a component of neurofilamentous lesions in sporadic and familial amyotrophic lateral sclerosis. Biochem Biophys Res Commun 2001,282(1),166-172
Chang-Hong R.; Wada M.; Koyama S.; Kimura H.; Arawaka S.; Kawanami T.; Kurita K.; Kadoya T.; Aoki M.; Itoyama Y.; Kato T.; Neuroprotective effect of oxidized galectin-1 in a transgenic mouse model of amyotrophic lateral sclerosis. Exp Neurol 2005,194(1),203-211
Kato T.; Ren C.H.; Wada M.; Kawanami T.; Galectin-1 as a potential therapeutic agent for amyotrophic lateral sclerosis. Curr Drug Targets 2005,6(4),407-418
Wang X.; Zhang S.; Lin F.; Chu W.; Yue S.; Elevated galectin-3 levels in the serum of patients with Alzheimer’s disease. Am J Alzheimers Dis Other Demen 2015,30(8),729-732
Ashraf G.M.; Baeesa S.S.; Investigation of Gal-3 expression pattern in serum and cerebrospinal fluid of patients suffering from neurodegenerative disorders. Front Neurosci 2018,12,430
Zhou J.Y.; Afjehi-Sadat L.; Asress S.; Duong D.M.; Cudkowicz M.; Glass J.D.; Peng J.; Galectin-3 is a candidate biomarker for amyotrophic lateral sclerosis: discovery by a proteomics approach. J Proteome Res 2010,9(10),5133-5141
Yan J.; Xu Y.; Zhang L.; Zhao H.; Jin L.; Liu W.G.; Weng L-H.; Li Z-H.; Chen L.; Increased expressions of plasma galectin-3 in patients with amyotrophic lateral sclerosis. Chin Med J (Engl) 2016,129(23),2797-2803
Cengiz T.; Türkboyları S.; Gençler O.S.; Anlar Ö.; The roles of galectin-3 and galectin-4 in the idiopatic Parkinson disease and its progression. Clin Neurol Neurosurg 2019,184
Sakaguchi M.; Shingo T.; Shimazaki T.; Okano H.J.; Shiwa M.; Ishibashi S.; Oguro H.; Ninomiya M.; Kadoya T.; Horie H.; Shibuya A.; Mizusawa H.; Poirier F.; Nakauchi H.; Sawamoto K.; Okano H.; A carbohydrate-binding protein, Galectin-1, promotes proliferation of adult neural stem cells. Proc Natl Acad Sci USA 2006,103(18),7112-7117
Yamane J.; Ishibashi S.; Sakaguchi M.; Kuroiwa T.; Kanemura Y.; Nakamura M.; Miyoshi H.; Sawamoto K.; Toyama Y.; Mizusawa H.; Okano H.; Transplantation of human neural stem/progenitor cells overexpressing galectin-1 improves functional recovery from focal brain ischemia in the Mongolian gerbil. Mol Brain 2011,4,35
Kurushima H.; Ohno M.; Miura T.; Nakamura T.Y.; Horie H.; Kadoya T.; Ooboshi H.; Kitazono T.; Ibayashi S.; Iida M.; Nakabeppu Y.; Selective induction of DeltaFosB in the brain after transient forebrain ischemia accompanied by an increased expression of galectin-1, and the implication of DeltaFosB and galectin-1 in neuroprotection and neurogenesis. Cell Death Differ 2005,12(8),1078-1096
Qu W.S.; Wang Y.H.; Wang J.P.; Tang Y.X.; Zhang Q.; Tian D.S.; Yu Z-Y.; Xie M.J.; Wang W.; Galectin-1 enhances astrocytic BDNF production and improves functional outcome in rats following ischemia. Neurochem Res 2010,35(11),1716-1724
Qu W.S.; Wang Y.H.; Ma J.F.; Tian D.S.; Zhang Q.; Pan D.J.Yu.; Yu Z.Y.; Xie M.J.; Wang J.P.; Wang W.; Galectin-1 attenuates astrogliosis-associated injuries and improves recovery of rats following focal cerebral ischemia. J Neurochem 2011,116(2),217-226
Wang J.; Xia J.; Zhang F.; Shi Y.; Wu Y.; Pu H.; Liou A.K.F.; Leak R.K.; Yu X.; Chen L.; Chen J.; Galectin-1-secreting neural stem cells elicit long-term neuroprotection against ischemic brain injury. Sci Rep 2015,5,9621
Rahimian R.; Béland L-C.; Kriz J.; Galectin-3: mediator of microglia responses in injured brain. Drug Discov Today 2018,23(2),375-381
Sirko S.; Irmler M.; Gascón S.; Bek S.; Schneider S.; Dimou L.; Obermann J.; De Souza Paiva D.; Poirier F.; Beckers J.; Hauck S.M.; Barde Y.A.; Götz M.; Astrocyte reactivity after brain injury-: The role of galectins 1 and 3. Glia 2015,63(12),2340-2361
Walther M.; Kuklinski S.; Pesheva P.; Guntinas-Lichius O.; Angelov D.N.; Neiss W.F.; Asou H.; Probstmeier R.; Galectin-3 is upregulated in microglial cells in response to ischemic brain lesions, but not to facial nerve axotomy. J Neurosci Res 2000,61(4),430-435
Doverhag C.; Hedtjärn M.; Poirier F.; Mallard C.; Hagberg H.; Karlsson A.; Sävman K.; Galectin-3 contributes to neonatal hypoxic-ischemic brain injury. Neurobiol Dis 2010,38(1),36-46
Lalancette-Hébert M.; Swarup V.; Beaulieu J.M.; Bohacek I.; Abdelhamid E.; Weng Y.C.; Sato S.; Kriz J.; Galectin-3 is required for resident microglia activation and proliferation in response to ischemic injury. J Neurosci 2012,32(30),10383-10395
Chip S.; Fernández-López D.; Li F.; Faustino J.; Derugin N.; Vexler Z.S.; Genetic deletion of galectin-3 enhances neuroinflammation, affects microglial activation and contributes to sub-chronic injury in experimental neonatal focal stroke. Brain Behav Immun 2017,60,270-281
Dong H.; Wang Z.H.; Zhang N.; Liu S.D.; Zhao J.J.; Liu S.Y.; Serum Galectin-3 level, not Galectin-1, is associated with the clinical feature and outcome in patients with acute ischemic stroke. Oncotarget 2017,8(65),109752-109761
Nishikawa H.; Nakatsuka Y.; Shiba M.; Kawakita F.; Fujimoto M.; Suzuki H.; Increased plasma galectin-3 preceding the development of delayed cerebral infarction and eventual poor outcome in non-severe aneurysmal subarachnoid hemorrhage. Transl Stroke Res 2018,9(2),110-119
Bresalier R.S.; Yan P.S.; Byrd J.C.; Lotan R.; Raz A.; Expression of the endogenous galactose-binding protein galectin-3 correlates with the malignant potential of tumors in the central nervous system. Cancer 1997,80(4),776-787
Verschuere T.; Toelen J.; Maes W.; Poirier F.; Boon L.; Tousseyn T.; Mathivet T.; Gerhardt H.; Mathieu V.; Kiss R.; Lefranc F.; Van Gool S.W.; De Vleeschouwer S.; Glioma-derived galectin-1 regulates innate and adaptive antitumor immunity. Int J Cancer 2014,134(4),873-884
Chou S.Y.; Yen S.L.; Huang C.C.; Huang E.Y.; Galectin-1 is a poor prognostic factor in patients with glioblastoma multiforme after radiotherapy. BMC Cancer 2018,18(1),105
Kuklinski S.; Pesheva P.; Heimann C.; Urschel S.; Gloor S.; Graeber S.; Herzog V.; Pietsch T.; Wiestler O.D.; Probstmeier R.; Expression pattern of galectin-3 in neural tumor cell lines. J Neurosci Res 2000,60(1),45-57
Strik H.M.; Schmidt K.; Lingor P.; Tönges L.; Kugler W.; Nitsche M.; Rabinovich G.A.; Bähr M.; Galectin-1 expression in human glioma cells: modulation by ionizing radiation and effects on tumor cell proliferation and migration. Oncol Rep 2007,18(2),483-488
Toussaint L.G.; Nilson A.E.; Goble J.M.; Ballman K.V.; James C.D.; Lefranc F.; Kiss R.; Uhm J.H.; Galectin-1, a gene preferentially expressed at the tumor margin, promotes glioblastoma cell invasion. Mol Cancer 2012,11,32
Liu Z.; Han H.; He X.; Li S.; Wu C.; Yu C.; Wang S.; Expression of the galectin-9-Tim-3 pathway in glioma tissues is associated with the clinical manifestations of glioma. Oncol Lett 2016,11(3),1829-1834
Van Woensel M.; Mathivet T.; Wauthoz N.; Rosière R.; Garg A.D.; Agostinis P.; Mathieu V.; Kiss R.; Lefranc F.; Boon L.; Belmans J.; Van Gool S.W.; Gerhardt H.; Amighi K.; De Vleeschouwer S.; Sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategy. Sci Rep 2017,7(1),1217
Yamaoka K.; Mishima K.; Nagashima Y.; Asai A.; Sanai Y.; Kirino T.; Expression of galectin-1 mRNA correlates with the malignant potential of human gliomas and expression of antisense galectin-1 inhibits the growth of 9 glioma cells. J Neurosci Res 2000,59(6),722-730
Camby I.; Belot N.; Rorive S.; Lefranc F.; Maurage C.A.; Lahm H.; Kaltner H.; Hadari Y.; Ruchoux M.M.; Brotchi J.; Zick Y.; Salmon I.; Gabius H.J.; Kiss R.; Galectins are differentially expressed in supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas, and significantly modulate tumor astrocyte migration. Brain Pathol 2001,11(1),12-26
Le Mercier M.; Fortin S.; Mathieu V.; Roland I.; Spiegl-Kreinecker S.; Haibe-Kains B.; Bontempi G.; Decaestecker C.; Berger W.; Lefranc F.; Kiss R.; Galectin 1 proangiogenic and promigratory effects in the Hs683 oligodendroglioma model are partly mediated through the control of BEX2 expression. Neoplasia 2009,11(5),485-496
Rorive S.; Belot N.; Decaestecker C.; Lefranc F.; Gordower L.; Micik S.; Maurage C-A.; Kaltner H.; Ruchoux M-M.; Danguy A.; Gabius H.J.; Salmon I.; Kiss R.; Camby I.; Galectin-1 is highly expressed in human gliomas with relevance for modulation of invasion of tumor astrocytes into the brain parenchyma. Glia 2001,33(3),241-255
Hancq S.; Salmon I.; Brotchi J.; Gabius H.J.; Heizmann C.W.; Kiss R.; Decaestecker C.; Detection of S100B, S100A6 and galectin-3 ligands in meningiomas as markers of aggressiveness. Int J Oncol 2004,25(5),1233-1240
Moiseeva E.P.; Williams B.; Goodall A.H.; Samani N.J.; Galectin-1 interacts with β-1 subunit of integrin. Biochem Biophys Res Commun 2003,310(3),1010-1016
Fortin S.; Le Mercier M.; Camby I.; Spiegl-Kreinecker S.; Berger W.; Lefranc F.; Kiss R.; Galectin-1 is implicated in the protein kinase C ε/vimentin-controlled trafficking of integrin-β1 in glioblastoma cells. Brain Pathol 2010,20(1),39-49
Strik H.M.; Kolodziej M.; Oertel W.; Basecke J.; Glycobiology in malignant gliomas: expression and functions of galectins and possible therapeutic options. Curr Pharm Biotechnol 2012,13(11),2299-2307
Binh N.H.; Satoh K.; Kobayashi K.; Takamatsu M.; Hatano Y.; Hirata A.; Tomita H.; Kuno T.; Hara A.; Galectin-3 in preneoplastic lesions of glioma. J Neurooncol 2013,111(2),123-132
Balan V.; Nangia-Makker P.; Raz A.; Galectins as cancer biomarkers. Cancers (Basel) 2010,2(2),592-610
Bailey L.A.; Jamshidi-Parsian A.; Patel T.; Koonce N.A.; Diekman A.B.; Cifarelli C.P.; Marples B.; Griffin R.J.; Combined temozolomide and ionizing radiation induces galectin-1 and galectin-3 expression in a model of human glioma. Tumor Microenviron Ther 2015,2,19-31
Danhier F.; Messaoudi K.; Lemaire L.; Benoit J.P.; Lagarce F.; Combined anti-Galectin-1 and anti-EGFR siRNA-loaded chitosan-lipid nanocapsules decrease temozolomide resistance in glioblastoma: in vivo evaluation. Int J Pharm 2015,481(1-2),154-161
Wu R.; Wu T.; Wang K.; Luo S.; Chen Z.; Fan M.; Xue D.; Lu H.; Zhuang Q.; Xu X.; Prognostic significance of galectin-1 expression in patients with cancer: a meta-analysis. Cancer Cell Int 2018,18,108
Ribeiro A.C.; Ferreira R.; Freitas R.; Plant Lectins: Bioactivities and Bioapplications. Studies in Natural Products Chemistry 2018,Vol. 58,1-42
Dan X.; Liu W.; Ng T.B.; Development and applications of lectins as biological tools in biomedical research. Med Res Rev 2016,36(2),221-247
Levy S.L.; White J.J.; Lackey E.P.; Schwartz L.; Sillitoe R.V.; WGA-Alexa conjugates for axonal tracing. Curr Protoc Neurosci 2017,79,1-28, 24
Hirabayashi J.; Yamada M.; Kuno A.; Tateno H.; Lectin microarrays: concept, principle and applications. Chem Soc Rev 2013,42(10),4443-4458
Hendrickson O.D.; Zherdev A.V.; Analytical application of lectins. Crit Rev Anal Chem 2018,48(4),279-292
Laaf D.; Bojarová P.; Elling L.; Křen V.; Galectin-carbohydrate interactions in biomedicine and biotechnology. Trends Biotechnol 2019,37(4),402-415
Wada J.; Makino H.; Galectins, galactoside-binding mammalian lectins: clinical application of multi-functional proteins. Acta Med Okayama 2001,55(1),11-17
Thijssen V.L.; Heusschen R.; Caers J.; Griffioen A.W.; Galectin expression in cancer diagnosis and prognosis: A systematic review. Biochim Biophys Acta 2015,1855(2),235-247
Dong R.; Zhang M.; Hu Q.; Zheng S.; Soh A.; Zheng Y.; Yuan H.; Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy (Review). Int J Mol Med 2018,41(2),599-614
Hayashi Y.; Jia W.; Kidoya H.; Muramatsu F.; Tsukada Y.; Takakura N.; Galectin-3 inhibits cancer metastasis by negatively regulating integrin β3 expression. Am J Pathol 2019,189(4),900-910
Girard A.; Magnani J.L.; Clinical trials and applications of galectin antagonists. Trends Glycosci Glyc 2018,30,SE211-SE220
Dings R.P.; Miller M.C.; Nesmelova I.; Astorgues-Xerri L.; Kumar N.; Serova M.; Chen X.; Raymond E.; Hoye T.R.; Mayo K.H.; Antitumor agent calixarene 0118 targets human galectin-1 as an allosteric inhibitor of carbohydrate binding. J Med Chem 2012,55(11),5121-5129
Hirani N.; Nicol L.; MacKinnon A.C.; Ford P.; Schambye H.; Nilsson U.; Leffler H.; Thomas T.; Knott O.; Gibbons M.; Simpson J.; Maher, T. TD139, a novel inhaled galectin-3 inhibitor for the treatment of idiopathic pulmonary fibrosis (IPF). results from the first in (IPF) patients study. QJM-. Int J Med (Dubai) 2016,109,S16-S16
Stegmayr J.; Lepur A.; Kahl-Knutson B.; Aguilar-Moncayo M.; Klyosov A.A.; Field R.A.; Oredsson S.; Nilsson U.J.; Leffler H.; Low or no inhibitory potency of the canonical galectin carbohydrate-binding site by pectins and galactomannans. J Biol Chem 2016,291(25),13318-13334
Floyd R.A.; Antioxidants, oxidative stress, and degenerative neurological disorders. Proc Soc Exp Biol Med 1999,222(3),236-245
Vila M.; Przedborski S.; Targeting programmed cell death in neurodegenerative diseases. Nat Rev Neurosci 2003,4(5),365-375
Urdinguio R.G.; Sanchez-Mut J.V.; Esteller M.; Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies. Lancet Neurol 2009,8(11),1056-1072